Breaking News, Promotions & Moves

GT Biopharma Appoints Gregory Berk CMO

Jeffrey S. Miller, M.D. will become Consulting Chief Scientific Officer, continuing to lead TriKE product candidate clinical trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

GT Biopharma, Inc., a clinical stage immuno-oncology company focused on therapeutics based on the Company’s natural killer (NK) cell engager, TriKE platform, has appointed Gregory Berk, M.D., Chief Medical Officer. Dr. Berk has served as a Director on GT Biopharma’s Board since November 2020, and resigns that post in conjunction with his appointment.   Also, Jeffrey S. Miller, M.D., who has supported GT Biopharma as the Company’s Consulting Chief Medical Officer since August ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters